The Impact of COVID-19 on Randomized Clinical Trials

IMPACT OF COVID-19 on Clinical Trials:

LEARN ON OPERATIONAL CHALLENGES TO CONSIDER, ESPECIALLY RELATED TO MISSING DATA AND PROTOCOL DEVIATIONS  

Today’s session is focusing on the impact of COVID-19 on clinical trials. Joining us to discuss further is Marc Buyse, Founder & Chief Scientific Officer and Everardo Saad, Medical Director of IDDI